Rhythm Pharmaceuticals Ownership | Who Owns Rhythm Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Rhythm Pharmaceuticals Ownership Summary


Rhythm Pharmaceuticals is owned by 94.92% institutional investors, 0.53% insiders, and 4.55% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.35% of RYTM shares. PRIMECAP Odyssey Aggressive Growth is the top mutual fund, with 7.28% of its assets in Rhythm Pharmaceuticals shares.

RYTM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRhythm Pharmaceuticals94.92%0.53%4.55%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de6.95M11.35%$389.10M
Blackrock6.74M11.21%$276.82M
Primecap management co/ca/6.57M10.73%$367.86M
Ra capital management6.08M9.94%$340.61M
Baker bros. advisors lp6.08M9.94%$340.60M
Perceptive advisors3.68M6.01%$206.03M
Vanguard group3.44M5.62%$192.72M
Nea management company2.91M4.75%$162.90M
Frazier life sciences management2.37M3.94%$97.37M
State street2.00M3.33%$82.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Checkpoint capital727.98K20.74%$40.75M
Nea management company2.91M9.19%$162.90M
Perceptive advisors3.68M5.68%$206.03M
Opaleye management500.00K4.90%$27.99M
Frazier life sciences management2.37M4.55%$97.37M
Ra capital management6.08M4.53%$340.61M
Baker bros. advisors lp6.08M3.64%$340.60M
Silverarc capital management273.90K3.35%$15.33M
Stempoint capital lp208.02K2.91%$11.64M
Rock springs capital management lp1.16M2.48%$65.09M

Top Buyers

HolderShares% AssetsChange
Janus henderson group1.22M0.03%621.43K
Driehaus capital management1.18M0.47%326.87K
Morgan stanley475.65K0.00%292.78K
Marshall wace, llp692.80K0.05%286.19K
Nisa investment advisors374.35K0.10%229.06K

Top Sellers

HolderShares% AssetsChange
Goldman sachs group1.81M0.02%-2.07M
Healthcare of ontario pension plan trust fund---1.11M
State street2.00M0.00%-1.01M
Commodore capital lp---650.00K
Primecap management co/ca/6.57M0.28%-645.72K

New Positions

HolderShares% AssetsChangeValue
Norges bank205.65K0.00%205.65K$11.51M
Nomura157.30K0.01%157.30K$6.46M
Walleye capital144.34K0.02%144.34K$8.08M
Balyasny asset management138.36K0.01%138.36K$7.75M
Hap trading109.80K0.04%109.80K$312.93K

Sold Out

HolderChange
Innealta capital-7.00
Nelson, van denburg & campbell wealth management group-10.00
Capital performance advisors llp-16.00
Allspring global investments-26.00
Global retirement partners-35.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241975.35%58,110,291-14.09%940.78%11220.43%50-12.28%
Sep 30, 20241877.47%67,638,955-2.40%1100.83%933.33%579.62%
Jun 30, 2024174-1.14%69,303,0851.97%1150.90%902.27%52-5.45%
Mar 31, 2024176-0.56%67,967,4711.91%1130.84%882.33%55-15.38%
Dec 31, 202317715.69%66,693,635-2.13%1150.83%86-4.44%6571.05%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
PRIMECAP Odyssey Aggressive Growth4.48M7.28%-314.92K
Vanguard Total Stock Mkt Idx Inv1.93M3.05%1.55K
Vanguard US Total Market Shares ETF1.92M3.03%2.33K
PRIMECAP Odyssey Growth1.81M2.94%-284.97K
iShares Russell 2000 ETF1.44M2.27%-12.43K
Polar Capital Biotech S Inc1.25M1.98%-
Vanguard Institutional Extnd Mkt Idx Tr790.27K1.25%1.16K
Federated Hermes Kaufmann Small Cap Grow740.07K1.20%-59.93K
Federated Hermes Kaufmann Small Cap A740.07K1.20%-59.93K
Federated Hermes Kaufmann R691.29K1.12%-148.71K

Recent Insider Transactions


DateNameRoleActivityValue
Apr 08, 2025Cramer Pamela J. Chief Human Resources OfficerSell$435.86K
Apr 08, 2025Cramer Pamela J. Chief Human Resources OfficerSell$402.00K
Apr 08, 2025Cramer Pamela J. Chief Human Resources OfficerSell$375.23K
Apr 08, 2025Cramer Pamela J. Chief Human Resources OfficerSell$35.40K
Apr 08, 2025Mazabraud Yann EVP, Head of InternationalSell$509.43K

Insider Transactions Trends


DateBuySell
2025 Q2-6
2025 Q1-35
2024 Q4-9
2024 Q3-17
2024 Q2-3

RYTM Ownership FAQ


Who Owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals shareholders are primarily institutional investors at 94.92%, followed by 0.53% insiders and 4.55% retail investors. The average institutional ownership in Rhythm Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Rhythm Pharmaceuticals exceeds.

Who owns the most shares of Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (6.95M shares, 11.35%), Blackrock (6.74M shares, 11.21%), and Primecap management co/ca/ (6.57M shares, 10.73%). Together, they hold 33.30% of Rhythm Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rhythm Pharmaceuticals?

Yes, BlackRock owns 11.21% of Rhythm Pharmaceuticals, totaling 6.74M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 276.82M$. In the last quarter, BlackRock increased its holdings by 212.28K shares, a 3.25% change.

Who is Rhythm Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Checkpoint capital is Rhythm Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 20.74% of its assets in 727.98K Rhythm Pharmaceuticals shares, valued at 40.75M$.

Who is the top mutual fund holder of Rhythm Pharmaceuticals shares?

PRIMECAP Odyssey Aggressive Growth is the top mutual fund holder of Rhythm Pharmaceuticals shares, with 7.28% of its total shares outstanding invested in 4.48M Rhythm Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools